March 2013 Editor's Picks: Products from Weiler Engineering and Pharma Technology Inc. (PTI) - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

March 2013 Editor's Picks: Products from Weiler Engineering and Pharma Technology Inc. (PTI)

Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

Weiler Engineering
All-electric, blow–fill–seal machine reduces particulate generation

The all-electric model of the Asep-Tech Model 628 blow–fill–seal machine from Weiler Engineering reduces particulate generation compared to the non-electric model, which is beneficial for parenteral applications. The Model 628 has the flexibility to produce sterile, liquid-filled, tamper-evident containers ranging in size from 0.5 mL up to 500 mL, in full-scale production quantities. A two-piece, stepped-base design allows easy maintenance and convenient product discharge. An integral product buffer tank is designed to meet tight fill tolerances. Additional models are available to fulfill higher output and/or larger container size requirements.

Pharma Technology Inc. (PTI)
System combines tablet deduster, metal detector, and tablet tester on one base

The AIO All-In-One Tablet Deduster and Tester System from Pharma Technology Inc. (PTI) includes PTI’s PharmaFlex segmented deduster spiral, a metal detector, and an in-process tablet tester on one machine base. The tablet tester measures weight, hardness, and thickness at regular intervals and feeds data back to the press where it is recorded and can be used to adjust the process. The tester can be positioned on any of the three sides of the deduster’s base and offers cable-free connections for power and data storage.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Equipment and Processing Report,
Click here